Magnetic cell delivery for peripheral arterial disease: A theoretical framework

Medical Physics

Volumn 38, Issue 7, 2011, Pages 3932-3943

  Riegler, Johannes ^a,b   Lau, Kevin D ^b   Garcia Prieto, Ana ^c   Price, Anthony N ^d   Richards, Toby ^e   Pankhurst, Quentin A ^f   Lythgoe, Mark F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^f DAVY FARADAY RESEARCH LABORATORY   (United Kingdom)

Author keywords

computational fluid dynamics; fluid structure interaction; Halbach cylinder; magnetic cell delivery; magnetic resonance imaging; peripheral arterial disease

Indexed keywords

CELLS; COMPUTATIONAL FLUID DYNAMICS; COMPUTATIONAL GEOMETRY; CYLINDERS (SHAPES); CYTOLOGY; EFFICIENCY; HEMODYNAMICS; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETIZATION; MAGNETS;

COMPUTATIONAL FLUID DYNAMICS SIMULATIONS; HALBACH CYLINDERS; MAGNETIC CELLS; MAGNETIC FIELD DISTRIBUTION; MAGNETIZATION ORIENTATION; PERIPHERAL ARTERIAL DISEASE; POSTERIOR TIBIAL ARTERY; THEORETICAL FRAMEWORK;

FLUID STRUCTURE INTERACTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 79960215284     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3593363     Document Type: Article

References (62)

1. A. T. Hirsch, M. H. Criqui, D. Treat -Jacobson, J. G. Regensteiner, M. A. Creager, J. W. Olin, S. H. Krook, D. B. Hunninghake, A. J. Comerota, M. E. Walsh, M. M. McDermott, and W. R. Hiatt, "Peripheral arterial disease detection, awareness, and treatment in primary care.," JAMA J. Am. Med. Assoc. 286, 1317-1324 (2001). 10.1001/jama.286.11.1317 (Pubitemid 33015522)
2. E. Selvin and T. P. Erlinger, "Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the national health and nutrition examination survey, 1999-2000.," Circulation 110, 738-743 (2004). 10.1161/01.CIR.0000137913.26087.F0 (Pubitemid 39056275)
3. American Heart Association, Heart disease and stroke statistics-2004, Dallas (2004).
4. G. J. Becker, T. E. McClenny, M. E. Kovacs, R. D. Raabe, and B. T. Katzen, "The importance of increasing public and physician awareness of peripheral arterial disease.," J. Vasc. Interv. Radiol. 13, 7-11 (2002). 10.1016/S1051-0443(07)60002-5 (Pubitemid 34094580)
5. L. Graziani and A. Piaggesi, "Indications and clinical outcomes for below knee endovascular therapy: Review article.," Cathet. Cardiovasc. Intervent. 75, 433-443 (2010) 10.1002/ccd.22287.
6. C. J. White and W. A. Gray, "Endovascular therapies for peripheral arterial disease: An evidence-based review.," Circulation 116, 2203-2215 (2007). 10.1161/CIRCULATIONAHA.106.621391 (Pubitemid 350060358)
7. R. Hoffmann, G. S. Mintz, G. R. Dussaillant, J. J. Popma, A. D. Pichard, L. F. Satler, K. M. Kent, J. Griffin, and M. B. Leon, "Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study.," Circulation 94, 1247-1254 (1996). (Pubitemid 26307249)
8. R. Kornowski, M. K. Hong, F. O. Tio, O. Bramwell, H. Wu, and M. B. Leon, "In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia.," J. Am. Coll. Cardiol. 31, 224-230 (1998). 10.1016/S0735-1097(97)00450-6 (Pubitemid 28064746)
9. A. W. Heldman, L. Cheng, G. M. Jenkins, P. F. Heller, D. W. Kim, M. Ware, Jr., C. Nater, R. H. Hruban, B. Rezai, B. S. Abella, K. E. Bunge, J. L. Kinsella, S. J. Sollott, E. G. Lakatta, J. A. Brinker, W. L. Hunter, and J. P. Fr Öhlich, "Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.," Circulation 103, 2289-2295 (2001). (Pubitemid 32433720)
10. D. Kong, L. G. Melo, A. A. Mangi, L. Zhang, M. Lopez -Ilasaca, M. A. Perrella, C. C. Liew, R. E. Pratt, and V. J. Dzau, "Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.," Circulation 109, 1769-1775 (2004). 10.1161/01.CIR.0000121732. 85572.6F (Pubitemid 38500680)
11. N. Werner, S. Junk, U. Laufs, A. Link, K. Walenta, M. Bohm, and G. Nickenig, "Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury.," Circ. Res. 93, e17-e24 (2003). 10.1161/01.RES.0000083812.30141.74
12. S. Windecker, I. Mayer, G. De Pasquale, W. Maier, O. Dirsch, P. De Groot, Y. P. Wu, G. Noll, B. Leskosek, B. Meier, and O. M. Hess, "Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia.," Circulation 104, 928-933 (2001). 10.1161/hc3401.093146 (Pubitemid 32778045)
13. J. Aoki, P. W. Serruys, H. van Beusekom, A. T. L. Ong, E. P. McFadden, G. Sianos, W. J. van der Giessen, E. Regar, P. J. de Feyter, H. R. Davis, S. Rowland, and M. J. B. Kutryk, "Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry.," J. Am. Coll. Cardiol. 45, 1574-1579 (2005). 10.1016/j.jacc.2005.01.048 (Pubitemid 40704488)
14. B. Lagerqvist, S. K. James, U. Stenestrand, J. Lindb äck, T. Nilsson, and L. Wallentin, "Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.," N. Engl. J. Med. 356, 1009-1019 (2007). 10.1056/NEJMoa067722 (Pubitemid 46376801)
15. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J. M. Isner, "Isolation of putative progenitor endothelial cells for angiogenesis.," Science 275, 964-966 (1997). 10.1126/science.275.5302.964 (Pubitemid 27087709)
16. R. Waksman, R. Baffour, R. Pakala, M. Scheinowitz, D. Hellinga, R. Seabron, R. Chan, F. Kolodgie, and R. Virmani, "Effects of exogenous peripheral-blood-derived endothelial progenitor cells or unfractionated bone-marrow-derived cells on neointimal formation and inflammation in cholesterol-fed, balloon-denuded, and radiated iliac arteries of inbred rabbits.," Cardiovasc. Revasc. Med. 10, 110-116 (2004). 10.1016/j.carrev.2009.02.001
17. M. Peichev, A. J. Naiyer, D. Pereira, Z. Zhu, W. J. Lane, M. Williams, M. C. Oz, D. J. Hicklin, L. Witte, M. A. S. Moore, and S. Rafii, "Expression of VEGFR-2 and AC133 by circulating human CD34 + cells identifies a population of functional endothelial precursors.," Blood 95, 952-958 (2000). (Pubitemid 30062717)
18. D. Hou, E. A.-S. Youssef, T. J. Brinton, P. Zhang, P. Rogers, E. T. Price, A. C. Yeung, B. H. Johnstone, P. G. Yock, and K. L. March, "Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials.," Circulation 112, I150-1156 (2005) 10.1161/ CIRCULATIONAHA.104.526749.
19. F. Pelliccia, C. Cianfrocca, G. Rosano, G. Mercuro, G. Speciale, and V. Pasceri, "Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.," J. Am. Coll. Cardiol. Intv. 3, 78-86 (2010) 10.1016/j.jcin.2009.10.020.
20. A. S. Lübbe, C. Bergemann, H. Riess, F. Schriever, P. Reichardt, K. Possinger, M. Matthias, B. Dorken, F. Herrmann, R. Gurtler, P. Hohenberger, N. Haas, R. Sohr, B. Sander, A. J. Lemke, D. Ohlendorf, W. Huhnt, and D. Huhn, "Clinical experiences with magnetic drug targeting: A phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors.," Cancer Res. 56, 4686-4693 (1996). (Pubitemid 26338071)
21. C. Alexiou, D. Diehl, P. Henninger, H. Iro, R. Rockelein, W. Schmidt, and H. Weber, "A high field gradient magnet for magnetic drug targeting.," IEEE Trans. Appl. Supercond. 16, 1527-1530 (2006). 10.1109/TASC.2005.864457 (Pubitemid 44150135)
22. P. Dames, B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, J. Rosenecker, and C. Rudolph, "Targeted delivery of magnetic aerosol droplets to the lung.," Nat. Nanotechnol 2, 495-499 (2007). 10.1038/nnano.2007.217 (Pubitemid 47220067)
23. C. Plank, M. Anton, C. Rudolph, J. Rosenecker, and F. KrÖtz, "Enhancing and targeting nucleic acid delivery by magnetic force.," Expert Opin. Biol. Ther. 3, 745-758 (2003). 10.1517/14712598.3.5.745 (Pubitemid 36934974)
24. S. V. Pislaru, A. Harbuzariu, R. Gulati, T. Witt, N. P. Sandhu, R. D. Simari, and G. S. Sandhu, "Magnetically targeted endothelial cell localization in stented vessels.," J. Am. Coll. Cardiol. 48, 1839-1845 (2006). 10.1016/j.jacc.2006.06.069 (Pubitemid 44648636)
25. B. Polyak, I. Fishbein, M. Chorny, I. Alferiev, D. Williams, B. Yellen, G. Friedman, and R. J. Levy, "High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.," Proc. Natl. Acad. Sci. U. S. A. 105, 698-703 (2008). 10.1073/pnas.0708338105 (Pubitemid 351171771)
26. P. G. Kyrtatos, P. Lehtolainen, M. Junemann -Ramirez, A. Garcia -Prieto, A. N. Price, J. F. Martin, D. G. Gadian, Q. A. Pankhurst, and M. F. Lythgoe, "Magnetic tagging increases delivery of circulating progenitors in vascular injury.," JACC: Cardiovasc. Interv. 2, 794-802 (2009). 10.1016/j.jcin.2009.05.014
27. A. Weber, I. Pedrosa, A. Kawamoto, N. Himes, J. Munasinghe, T. Asahara, N. M. Rofsky, and D. W. Losordo, "Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease.," Eur. J. Cardiothorac Surg. 26, 137-143 (2004). 10.1016/j.ejcts.2004.03.024 (Pubitemid 38759937)
28. P. J. Cregg, K. Murphy, and A. Mardinoglu, "Inclusion of magnetic dipole-dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting.," J. Magn. Magn. Mater. 321, 3893-3898 (2009). 10.1016/j.jmmm.2009.07.056
29. M. C. Erica, G. M. Peter, and K. E. John, "Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting.," Med. Phys. 37, 175-182 (2010). 10.1118/1.3271344
30. A. Nacev, C. Beni, O. Bruno, and B. Shapiro, "Magnetic nanoparticle transport within flowing blood and into surrounding tissue.," Nanomedicine 5, 1459-1466 (2010). 10.2217/nnm.10.104
31. J. W. M. Bulte, T. Douglas, B. Witwer, S. C. Zhang, E. Strable, B. K. Lewis, H. Zywicke, B. Miller, P. van Gelderen, B. M. Moskowitz, I. D. Duncan, and J. A. Frank, "Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells.," Nat. Biotechnol. 19, 1141-1147 (2001). 10.1038/nbt1201-1141 (Pubitemid 33115700)
32. I. J. de Vries, W. J. Lesterhuis, J. O. Barentsz, P. Verdijk, J. H. van Krieken, O. C. Boerman, W. J. G. Oyen, J. J. Bonenkamp, J. B. Boezeman, G. J. Adema, J. W. M. Bulte, T. W. J. Scheenen, C. J. A. Punt, A. Heerschap, and C. G. Figdor, "Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.," Nat. Biotechnol. 23, 1407-1413 (2005). 10.1038/nbt1154 (Pubitemid 41679393)
33. C. Alexiou, R. Jurgons, R. J. Schmid, C. Bergemann, J. Henke, W. Erhardt, E. Huenges, and F. Parak, "Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.," J. Drug Target. 11, 139-149 (2003). 10.3109/1061186031000150791 (Pubitemid 37236327)
34. U. O. Häfeli, S. M. Sweeney, B. A. Beresford, J. L. Humm, and R. M. Macklis, "Effective targeting of magnetic radioactive90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.," Nucl. Med. Biol. 22, 147-155 (1995). 10.1016/0969-8051(94) 00124-3
35. S. I. Takeda, F. Mishima, S. Fujimoto, Y. Izumi, and S. Nishijima, "Development of magnetically targeted drug delivery system using superconducting magnet.," J. Magn. Magn. Mater. 311, 367-371 (2007). 10.1016/j.jmmm.2006.10.1195 (Pubitemid 46401053)
36. M. O. Avilés, A. D. Ebner, and J. A. Ritter, "Implant assisted-magnetic drug targeting: Comparison of in vitro experiments with theory.," J. Magn. Magn. Mater. 320, 2704-2713 (2008). 10.1016/j.jmmm.2008. 06.001
37. H. Azuma, N. Funayama, T. Kubota, and M. Ishikawa, "Regeneration of endothelial cells after balloon denudation of the rabbit carotid artery and changes in responsiveness.," Jpn. J. Pharmacol. 52, 541-552 (1990). 10.1254/jjp.52.541 (Pubitemid 20127312)
38. D. Y. Hui, "Intimal hyperplasia in murine models.," Curr. Drug Targets 9, 251-260 (2008). 10.2174/138945008783755601 (Pubitemid 351843607)
39. T. A. Painter, "Myointimal hyperplasia: Pathogenesis and implications. 2. Animal injury models and mechanical factors.," Artif. Organs 15, 103-118 (1991). 10.1111/j.1525-1594.1991.tb00768.x
40. Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, "Applications of magnetic nanoparticles in biomedicine.," J. Phys. D: Appl. Phys. 36, R167-R181 (2003). 10.1088/0022-3727/36/13/201
41. K. Halbach, "Design of permanent multipole magnets with oriented rare earth cobalt material.," Nucl. Instrum. Methods 169, 1-10 (1980). 10.1016/0029-554X(80)90094-4 (Pubitemid 11473624)
42. Neodymium-Iron-Boron Magnets. http://www.tdk.co.jp/tefe02/e331.pdf.
43. Sintered ferrite magnets. http://www.magnetsales.co.uk/sintered-ferrite. htm.
44. Segment version 1.8 R0462 (http://segment.heiberg.se).
45. E. Heiberg, J. Sj Ögren, M. Ugander, M. Carlsson, H. Engblom, and H. Arheden, "Design and validation of Segment-freely available software for cardiovascular image analysis.," BMC Med. Imaging 10, 1-13 (2010). 10.1186/1471-2342-10-1
46. X. Cui, C. Labarrere, L. He, S. Cheng, H. Siderys, R. Kovacs, and D. Gao, "Cryopreservation and microsurgical implantation of rabbit carotid arteries.," Cell Preserv. Technol 1, 121-128 (2002). 10.1089/ 153834402320882629 (Pubitemid 36950494)
47. H. Sato, M. Katano, T. Takigawa, and T. Masuda, "Estimation for the elasticity of vascular endothelial cells on the basis of atomic force microscopy and Young's modulus of gelatin gels.," Polym. Bul1 47, 375-381 (2001). 10.1007/s289-001-8195-z (Pubitemid 33151712)
48. R. Bjørk, C. R. H. Bahl, A. Smith, and N. Pryds, "Optimization and improvement of Halbach cylinder design.," J. Appl. Phys. 104, 013910-013919 (2008). 10.1063/1.2952537
49. M. Arruebo, R. Fernández-Pacheco, M. R. Ibarra, and J. Santamará, "Magnetic nanoparticles for drug delivery.," Nanotoday 2, 22-32 (2007) 10.1016/S1748-0132(07)70084-1. (Pubitemid 46695431)
50. J. Dobson, "Magnetic nanoparticles for drug delivery.," Drug Dev. Res. 67, 55-60 (2006). 10.1002/ddr.v67:1 (Pubitemid 43765049)
51. A. Kumar, P. K. Jena, S. Behera, R. F. Lockey, S. Mohapatra, and S. Mohapatra, "Multifunctional magnetic nanoparticles for targeted delivery.," Nanomedicine 6, 64-69 (2009) 10.1016/j.nano.2009.04.002.
52. R. S. Molday, S. P. S. Yen, and A. Rembaum, "Application of magnetic microspheres in labelling and separation of cells.," Nature (London) 437 - 438 (1977) 10.1038/268437a0.
53. A. S. Arbab, G. T. Yocum, A. M. Rad, A. Y. Khakoo, V. Fellowes, E. J. Read, and J. A. Frank, "Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.," NMR Biomed. 18, 553-559 (2005). 10.1002/nbm.v18:8 (Pubitemid 43013896)
54. E. M. Shapiro, L. N. Medford -David, T. M. Fahmy, C. E. Dunbar, and A. P. Koretsky, "Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI.," Contrast Media Mol. Imaging 2, 147-153 (2007). 10.1002/cmmi.v2:3 (Pubitemid 47180347)
55. U. O. Häfeli, K. Gilmour, A. Zhou, S. Lee, and M. E. Hayden, "Modeling of magnetic bandages for drug targeting: Button vs. Halbach arrays.," J. Magn. Magn. Mater. 311, 323-329 (2007). 10.1016/j.jmmm.2006. 10.1152 (Pubitemid 46401006)
56. P. J. Cregg, K. Murphy, A. Mardinoglu, and A. Prina -Mello, "Many particle magnetic dipole-dipole and hydrodynamic interactions in magnetizable stent assisted magnetic drug targeting.," J. Magn. Magn. Mater. 322, 2087-2094 (2010). 10.1016/j.jmmm.2010.01.038
57. J. Ally, B. Martin, M. Behrad Khamesee, W. Roa, and A. Amirfazli, "Magnetic targeting of aerosol particles for cancer therapy.," J. Magn. Magn. Mater. 293, 442-449 (2005). 10.1016/j.jmmm.2005.02.038 (Pubitemid 40608964)
58. J. Riegler, B. Allain, R. J. Cook, M. F. Lythgoe, and Q. A. Pankhurst, "Magnetically assisted delivery of cells using a magnetic resonance imaging system.," J. Phys. D: Appl. Phys. 44, 055001-055011 (2011). 10.1088/0022-3727/44/5/055001
59. J. Riegler, J. A. Wells, P. G. Kyrtatos, A. N. Price, Q. A. Pankhurst, and M. F. Lythgoe, "Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system.," Biomaterials 31, 5366-5371 (2010). 10.1016/j.biomaterials.2010.03.032
60. K. A. Hinds, J. M. Hill, E. M. Shapiro, M. O. Laukkanen, A. C. Silva, C. A. Combs, T. R. Varney, R. S. Balaban, A. P. Koretsky, and C. E. Dunbar, "Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.," Blood 102, 867-872 (2003). 10.1182/blood-2002-12-3669 (Pubitemid 36917777)
61. H. Chen, M. D. Kaminski, P. Pytel, L. Macdonald and A. J. Rosengart, "Capture of magnetic carriers within large arteries using external magnetic fields.," J. Drug Target. 16, 262-268 (2008). 10.1080/10611860801900892 (Pubitemid 351622355)
62. See supplementary material at http://dx.doi.org/10.1118/1.3593363" E-MPHYA6-38-049106 for a movie showing the behavior of a magnetically labelled cell close to the vessel wall. For more information on EPAPS, see http://www.aip.org/pubservs/epaps.html